Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 256
Filter
1.
Acta Physiol (Oxf) ; 222(1)2018 01.
Article in English | MEDLINE | ID: mdl-28470828

ABSTRACT

Several explanations for the diverse results in research on foetal alcohol spectrum disorders or alcohol-related neurodevelopmental disorder might be at hand: timing, amount and patterns of alcohol exposure, as well as complex epigenetic responses. The genetic background of the offspring and its interaction with other prenatal and post-natal environmental cues are likely also of importance. In the present report, key findings about the possible effects of low and moderate doses of maternal alcohol intake on the neuropsychological development of the offspring are reviewed and plausible mechanisms discussed. Special focus is put on the serotonergic system within developmental and gene-environment frameworks. The review also suggests guidelines for future studies and also summarizes some of to-be-answered questions of relevance to clinical practice. Contradictory findings and paucity of studies on the effects of exposure to low alcohol levels during foetal life for the offspring's neuropsychological development call for large prospective studies, as well as for studies including neuroimaging and multi-omics analyses to dissect the neurobiological underpinnings of alcohol exposure-related phenotypes and to identify biomarkers. Finally, it remains to be investigated whether any safe threshold of alcohol drinking during pregnancy can be identified.


Subject(s)
Alcohol Drinking/adverse effects , Brain/drug effects , Fetal Alcohol Spectrum Disorders/psychology , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/psychology , Animals , Central Nervous System Depressants/adverse effects , Ethanol/adverse effects , Female , Humans , Pregnancy
2.
BMC Musculoskelet Disord ; 18(1): 507, 2017 Dec 01.
Article in English | MEDLINE | ID: mdl-29195501

ABSTRACT

BACKGROUND: The COMT (Catechol-O-Methyl Transferase) gene may influence a person's vulnerability to develop long-term pain and some COMT single nucleotide polymorphisms (SNPs) may associate with patterns of acute or chronic pain. Many patients with whiplash-associated disorders (WADs) suffer from long-term pain and other related symptoms, but it is less known if genetic factors play a role in the recovery process. The primary aim of this study was to evaluate whether self-reported non-recovery, including pain, was related to COMT genotype in patients with WAD. The secondary aim was to investigate whether or not background factors, including mental health, were related to genotype and non-recovery. METHODS: A total of 133 patients with neck pain after a whiplash trauma were included. Background factors were collected and blood samples were taken during the acute phase after the accident. DNA was isolated from blood and used to genotype the SNPs rs6269, rs4633, rs4818 and rs4680 in the COMT gene; additionally haplotypes were estimated and haplogenotypes inferred. The patients were followed up after 12 months and asked to rate their recovery including pain, mental health and quality of life. RESULTS: The overall reported non-recovery rate at 12 months was 44% with no significant differences in distribution of the COMT haplotypes. High levels of self-reported pain (OR 7.2) and anxiety (OR 4.4) after the accident were associated with non-recovery, but not related to the haplotypes. None of the other background factors were related to the haplotypes or non-recovery. CONCLUSION: No association between self-reported non-recovery or pain levels and COMT haplotypes in patients with acute whiplash injuries could be detected. Independent replications are necessary to discard the hypothesis that COMT haplotypes do not influence non-recovery or pain levels in patients with acute whiplash injuries. High levels of initial pain and anxiety were associated with non-recovery, thereby confirming previously published reports.


Subject(s)
Anxiety/psychology , Catechol O-Methyltransferase/genetics , Chronic Pain/genetics , Neck Pain/genetics , Whiplash Injuries/complications , Adult , Chronic Pain/etiology , Chronic Pain/psychology , Chronic Pain/therapy , Europe , Female , Follow-Up Studies , Haplotypes/genetics , Humans , Male , Middle Aged , Neck Pain/etiology , Neck Pain/psychology , Neck Pain/therapy , Pain Measurement , Polymorphism, Single Nucleotide , Quality of Life , Randomized Controlled Trials as Topic , Self Report , Whiplash Injuries/psychology , Whiplash Injuries/therapy
3.
Behav Genet ; 41(2): 262-72, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20734127

ABSTRACT

The present study investigated a possible interaction between a functional polymorphism in the MAOA gene promoter (MAOA-VNTR) and childhood maltreatment in the prediction of adolescent male and female delinquency. A cohort of 1,825 high school students, 17-18 years old, completed an anonymous questionnaire during class hours which included questions on childhood maltreatment, sexual abuse, and delinquency. Saliva samples were collected for DNA isolation, and analyzed for the MAOA-VNTR polymorphism. Self-reported maltreatment was a strong risk factor for adolescent delinquent behavior. The MAOA genotype also showed a significant main effect when controlled for maltreatment. Boys with a short variant and girls with one or two long variants of the polymorphism showed a higher risk for delinquency when exposed to maltreatment. Our results confirm previous findings of an interaction between the MAOA-VNTR polymorphism and self-reported maltreatment. Results for boys and girls differ according to MAOA-VNTR genotype and direction of phenotypic expression.


Subject(s)
Child Abuse , Juvenile Delinquency , Monoamine Oxidase/genetics , Adolescent , Alleles , Cohort Studies , Environment , Female , Genotype , Humans , Male , Models, Genetic , Polymorphism, Genetic , Promoter Regions, Genetic , Surveys and Questionnaires
4.
J Neural Transm (Vienna) ; 117(9): 1077-81, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20690033

ABSTRACT

Genes involved in alcoholism have consensus sites for the transcription factor activator protein (TFAP) 2beta. In the present study, we investigated TFAP-2beta protein levels in the ethanol-preferring alko, alcohol (AA) and the ethanol-avoiding alko, non-alcohol (ANA) rat lines. Furthermore, basal and ethanol-induced TFAP-2beta levels were examined in Wistar rats exposed to different early postnatal environments that are known to affect later ethanol consumption. Taken together, we found differences in brainstem TFAP-2beta protein between the AA and ANA rats.


Subject(s)
Alcohol Drinking/metabolism , Brain Stem/metabolism , Ethanol/pharmacology , Maternal Deprivation , Social Environment , Transcription Factor AP-2/metabolism , Alcohol Drinking/genetics , Analysis of Variance , Animals , Rats , Rats, Wistar , Transcription Factor AP-2/genetics
5.
Eur Psychiatry ; 25(5): 304-6, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20447806

ABSTRACT

In summary, genetics, as well as foetal and early life environmental factors shape the size or capacity of our monoamine systems, of which the serotonergic one might play a leading role. Those constitutional properties then form the biological basis for personality traits, such as impulsiveness and "sensation seeking", which interact with psychosocial settings and life events to form a pattern of reactivity to a current life event or psychosocial situation, shown as a high or low order of magnitude of gene-environment interaction. In the present paper emphasis is put on the role of genotypes of the serotonin transporter, of monoamine oxidases A and B, and of platelet monoamine oxidase B activity, which all have been shown to be of importance for behaviour and with obvious effects of interactions with environment. Under unfortunate circumstances constitutional properties might be strong enough to result in vulnerability for suicide, even with a modest influence of environment.


Subject(s)
Serotonin/genetics , Social Environment , Suicide , Humans , Monoamine Oxidase/genetics , Personality/genetics , Serotonin Plasma Membrane Transport Proteins/genetics
6.
J Neural Transm (Vienna) ; 114(6): 713-6, 2007.
Article in English | MEDLINE | ID: mdl-17406964

ABSTRACT

X chromosome inactivation in mammalian females occurs early in embryonic development and renders most genes on the inactive X chromosome transcriptionally silenced. As a consequence, females will display an X chromosomal parent-of-origin mosaicism with regard to which parental allele that is expressed. Some genes however, escape inactivation and will therefore be expressed from both alleles. In this study we have investigated if the X-linked MAO-A gene have bi- or mono-allelic expression. This information would indicate whether or not MAO-A gene dosage could potentially explain the observed gender differences that show functional connections to the serotonin system, such as aggression and impulsiveness. To investigate the X inactivation status of MAO-A we have used primary clonal cell cultures, on which allelic expression was assessed with RFLP analysis. Our results show that the MAO-A gene has mono-allelic expression in these cells. This could have important implications for understanding traits that display gender differences.


Subject(s)
Dosage Compensation, Genetic/genetics , Gene Expression Regulation, Enzymologic/genetics , Monoamine Oxidase/biosynthesis , Monoamine Oxidase/genetics , Sex Characteristics , X Chromosome Inactivation/genetics , Brain Chemistry/genetics , Cells, Cultured , Clone Cells , Female , Fibroblasts/cytology , Fibroblasts/enzymology , Genes, X-Linked/genetics , Humans , Male , Mental Disorders/genetics , Mental Disorders/metabolism , Mental Disorders/physiopathology , Polymorphism, Restriction Fragment Length , Serotonin/metabolism , Skin/cytology , Skin/enzymology
7.
J Neural Transm (Vienna) ; 114(6): 817-22, 2007.
Article in English | MEDLINE | ID: mdl-17426915

ABSTRACT

The importance of an interaction between environment and biological factors for the expression for a particular behaviour is illustrated by results from a series of adolescents in which effects of platelet MAO activity and psychosocial environment on criminality was investigated. In a favourable environment platelet MAO-B activity was not associated with criminality, while a very strong association was found in adolescents from a bad psychosocial environment. Essentially similar findings were obtained when a MAO-A promoter polymorphism was analysed instead of platelet MAO-B activity. In boys, presence of the low functioning allele seemed to be protective against criminal activity in combination with a good environment, while it predisposed for criminality in a bad psycho-social environment. In girls, instead, homozygosity for the high activity MAO-A allele interacted with environment to predict criminality. Possible mechanisms underlying the role of monoamine oxidases for behaviour are discussed.


Subject(s)
Brain/enzymology , Genetic Predisposition to Disease/genetics , Monoamine Oxidase/genetics , Social Behavior Disorders/enzymology , Social Behavior Disorders/genetics , Adolescent , Aging/genetics , Brain/growth & development , Brain/physiopathology , Female , Genotype , Humans , Male , Sex Characteristics , Social Behavior Disorders/physiopathology
8.
Cognition ; 102(1): 84-100, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16412409

ABSTRACT

We hypothesized that women with Turner syndrome (45,X) with a single X-chromosome inherited from their mother may show mentalizing deficits compared to women of normal karyotype with two X-chromosomes (46,X). Simple geometrical animation events (two triangles moving with apparent intention in relation to each other) which usually elicit mental-state descriptions in normally developing people, did not do so to the same extent in women with Turner syndrome. We then investigated the potential role in this deficit played by monoamine oxidase B enzymatic activity. MAO-B activity reflects central serotonergic activity, and by implication the functional integrity of neural circuits implicated in mentalizing. Platelet MAO-B was substantially reduced in Turner syndrome. However, contrary to prediction, in this (relatively small) sample there was no association between MAO-B enzymatic activity and mentalizing skills in participants with and without Turner syndrome.


Subject(s)
Chromosomes, Human, X/genetics , Cognition Disorders/genetics , Monoamine Oxidase/genetics , Monosomy/genetics , Phenotype , Social Perception , Adult , Female , Humans , Karyotyping
9.
Pharmacology ; 78(2): 72-80, 2006.
Article in English | MEDLINE | ID: mdl-16960463

ABSTRACT

Histamine has many physiological roles in the brain and periphery. Neuronal histamine is metabolized almost exclusively by histamine N-methyltransferase. Although several neurotransmitter systems such as dopamine and 5-hydroxytryptamine have their specific reuptake system in their neurons and glial cells, a specific histamine reuptake system into the corresponding nerve terminals or glial cells has not yet been clearly elucidated. We characterized the uptake of histamine into the P2 fractions of rat brain homogenized in 0.32 mol/l sucrose using in vitro uptake techniques. [3H]histamine uptake increased with the increment of added protein amount and elapsed time. [3H]histamine uptake was also temperature-dependent. The uptake of [3H]histamine into the P2 fractions occurs by two saturable processes, a high-affinity and a low-affinity, characterized by K(m) values of 0.16 and 1.2 micromol/l, respectively. Na(+), Cl(-) and HCO(3)(-) ions were essential for the uptake of histamine in P2 fractions. [3H]histamine uptake was inhibited in the presence of several tricyclic antidepressants. In accordance with this, the endogenous release of histamine from brain slices evoked by 100 mmol/l K(+) was augmented in the presence of 20 micromol/l imipramine. These results further support the existence of a specific histamine uptake system in the brain, although the precise molecular entities have not been identified until now.


Subject(s)
Brain/metabolism , Histamine/pharmacokinetics , Synaptosomes/metabolism , Animals , Biological Transport , Brain/cytology , Cocaine/pharmacology , Dose-Response Relationship, Drug , Histamine/metabolism , Histamine Antagonists/pharmacology , Imipramine/pharmacology , In Vitro Techniques , Male , Rats , Rats, Sprague-Dawley , Receptors, Histamine/metabolism
10.
Biochem Biophys Res Commun ; 325(3): 1013-20, 2004 Dec 17.
Article in English | MEDLINE | ID: mdl-15541390

ABSTRACT

Semicarbazide-sensitive amine oxidase (SSAO) activity in plasma is increased in diabetes, and in particular, in diabetic patients with vascular complications. It has been speculated that SSAO is involved in the development of such complications due to the production of cytotoxic compounds. In this work, we have induced diabetes in a previously described mouse-model, overexpressing SSAO in smooth muscle cells. SSAO activity was estimated as well as expression of the endogenous mouse gene and human transgene using real-time PCR. Diabetes induced an increase in SSAO activity in serum, kidney, and adipose tissue of transgenic animals. An inverse correlation between SSAO activity and mouse SSAO mRNA levels was observed in transgenic animals with diabetes. These results further support the suggestion of a negative feedback control of the SSAO gene expression. The increased SSAO activity in diabetes is most likely dependent on post-transcriptional modifications or activation of existing inactive enzyme molecules.


Subject(s)
Amine Oxidase (Copper-Containing)/metabolism , Cell Adhesion Molecules/metabolism , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/enzymology , Mice, Transgenic/metabolism , Muscle, Smooth/enzymology , Adipose Tissue/enzymology , Alloxan , Amine Oxidase (Copper-Containing)/genetics , Animals , Cell Adhesion Molecules/genetics , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/genetics , Humans , Kidney/enzymology , Lung/enzymology , Mice , Organ Specificity , Recombinant Proteins/metabolism , Tissue Distribution
11.
Curr Med Chem ; 11(15): 2007-16, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15279564

ABSTRACT

Research on the association between platelet monoamine oxidase (MAO) activity and personality traits, such as sensation seeking and impulsiveness, is reviewed with an emphasis on early history and current situation. The effects of MAO-inhibiting compounds in cigarette smoke for the interpretation of this association are discussed and recent results confirming a true association between platelet MAO activity and personality and vulnerability, for e.g. type 2 alcoholism are presented. From a clinical point of view, the link between platelet MAO activity, which is highly genetically regulated and is stable in the individual, and personality traits, has had its greatest impact on the understanding of the nature of constitutional factors making individuals vulnerable, for e.g. substance abuse and other forms of sociopathic behaviour. The molecular mechanisms underlying the association between platelet MAO and behaviour are discussed and evidence that common transcriptional factors, e.g. within the AP-2 family, regulating both the expression of platelet MAO and components of the central monoaminergic systems, such as synthesising enzymes, receptors and transporters, are presented. A hypothesis is put forward, that such common transcription factors may not directly regulate platelet MAO expression, but rather mitochondrial density, or outer mitochondrial membrane surface.


Subject(s)
Biomarkers , Blood Platelets/enzymology , Monoamine Oxidase/blood , Personality/physiology , Animals , Humans
12.
Biochim Biophys Acta ; 1647(1-2): 88-91, 2003 Apr 11.
Article in English | MEDLINE | ID: mdl-12686114

ABSTRACT

Patients with diabetes mellitus and with vascular complications in particular, exhibit higher plasma activities of semicarbazide-sensitive amine oxidase (SSAO) compared to control subjects. It has been speculated that production of cytotoxic products of SSAO may cause endothelial damage and thus contribute to the development of diabetic vascular complications such as retino-, nephro-, and neuropathies as a result of SSAO activity.In order to explore the possibility that high SSAO activity contributes to the development of vascular complications in diabetes, we have performed two studies in patients with Type-2 diabetes quantifying plasma SSAO activity, HbA(1c), and urinary levels of the SSAO substrate, methylamine. We also examined the prevalence of retinopathy in these patients. Additionally, we have studied a model of transgenic mice expressing human SSAO in smooth muscle cells. The transgenic mice have an increased SSAO activity as well as mRNA expression. Histological studies revealed a specific aorta phenotype with a condensed and rigid vessel wall in some of the transgenic mice. No wild-type animals displayed this phenotype.In conclusion, we suggest that this transgenic mouse model may be of great value for increasing the knowledge about to what extent human SSAO contributes to vascular complications in diabetes, and also to which extent inhibition of SSAO can prevent the development of such complications.


Subject(s)
Amine Oxidase (Copper-Containing)/blood , Diabetes Mellitus, Type 2/enzymology , Diabetic Retinopathy/enzymology , Semicarbazides/pharmacology , Amine Oxidase (Copper-Containing)/genetics , Animals , Diabetes Mellitus, Type 2/complications , Humans , Mice , Mice, Transgenic
13.
Neuroscience ; 117(4): 1017-23, 2003.
Article in English | MEDLINE | ID: mdl-12654353

ABSTRACT

5-Hydroxytryptamine(2A) receptor agonists evoke the head-twitch response in mice. The head-twitch response in olfactory bulbectomized mice elicited by the administration of 5-hydroxytryptamine (40 microgram/mouse, i.c.v.) was increased about threefold as compared with controls on the 14th day after the operation. The injection of ketanserin (1 mg/kg, i.p.), a 5-hydroxytryptamine(2A) receptor antagonist, inhibited this enhancement of 5-hydroxytryptamine-induced head-twitch response after olfactory bulbectomized. On the 14th day, the number of head-twitch response induced by 5-hydroxytryptophan (40, 80 and 160 mg/kg, i.p.), a precursor of 5-hydroxytryptamine, did not differ between olfactory bulbectomized and control mice. Monoamine oxidase-B activity in the forebrain of olfactory bulbectomized mice was higher than that in controls while monoamine oxidase-A activities were unchanged. The 5-hydroxytryptamine uptake into synaptosomes in the forebrain homogenates of olfactory bulbectomized mice was lower than that in controls. These findings indicate that olfactory bulbectomized causes the enhancement of head-twitch response by a supersensitivity of 5-hydroxytryptamine(2A) receptors in cerebral cortex derived from degeneration of neurons projecting from the olfactory bulb.


Subject(s)
Cerebral Cortex/metabolism , Olfactory Bulb/cytology , Olfactory Pathways/cytology , Receptors, Serotonin/metabolism , Reflex/physiology , Serotonin/metabolism , Synaptic Transmission/physiology , 5-Hydroxytryptophan/pharmacology , Animals , Cerebral Cortex/drug effects , Denervation , Dose-Response Relationship, Drug , Ketanserin/pharmacology , Male , Mice , Monoamine Oxidase/metabolism , Movement/drug effects , Movement/physiology , Nerve Degeneration/metabolism , Nerve Degeneration/physiopathology , Olfactory Bulb/injuries , Olfactory Bulb/physiopathology , Olfactory Pathways/injuries , Olfactory Pathways/physiopathology , Receptor, Serotonin, 5-HT2A , Receptors, Serotonin/drug effects , Reflex/drug effects , Serotonin/pharmacology , Serotonin Antagonists/pharmacology , Synaptic Transmission/drug effects , Up-Regulation/physiology
14.
Methods Find Exp Clin Pharmacol ; 25(10): 785-92, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14735225

ABSTRACT

The inhibitory effects of 2-bromoethylamine (2-BEA), a derivative of ethylamine, on guinea pig lung semicarbazide-sensitive amine oxidase (SAO) have been studied. Preincubation with 2-BEA time-dependently inhibited SSAO activity. The mode of the initial phase of inhibition was competitive, with a Ki value of 52 microM. After preincubation at 37 degrees C for 2 h, the inhibition was noncompetitive and irreversible, as there was no recovery of SSAO activity by dilution of the inhibited samples. Kinetic analyses confirmed previous results with rat lung SSAO that 2-BEA is a suicide SSAO inactivator with a dissociation constant of 42 microM. This latter value is similar to that of the Ki value (52 microM) for the reversible phase of inhibition by 2-BEA. Addition of the nucleophilic compound 2-mercaptoethanol could not reduce the SSAO inhibition, indicating that inactivation could not be prevented by trapping the enzymatic reaction product from 2-BEA. This finding clearly indicates that the reaction product should not diffuse away from its site of genesis and agrees with one of the characteristics of suicide inhibitors. This conclusively excludes the possibility of an affinity-labeling mechanism.


Subject(s)
Amine Oxidase (Copper-Containing)/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Ethylamines/pharmacology , Lung/enzymology , Animals , Dose-Response Relationship, Drug , Guinea Pigs , In Vitro Techniques , Kinetics , Lung/drug effects , Male , Mercaptoethanol/pharmacology , Substrate Specificity
15.
Eur Neuropsychopharmacol ; 13(1): 11-7, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12480117

ABSTRACT

Imbalances in the midbrain monoaminergic systems have been implicated to play a role in neuropsychiatric conditions. Several genes in these systems have binding sites for transcription factor activating protein-2 (AP-2) in their regulatory regions. Thus, AP-2 may be a factor controlling the expression of genes in the monoaminergic systems important for maintaining normal psychiatric functions. The present study indicates that subchronic treatment with the antidepressant citalopram induces time-dependent changes in DNA-binding activity and levels of transcription factor AP-2 in rat whole brain. Rats were treated with citalopram (10 mg/kg) for 1, 3, 7 and 21 days. Animals treated for 7 days had significantly decreased DNA-binding activity and levels of AP-2 alpha and AP-2 beta isoforms when compared to saline-treated animals. There was no observed difference between citalopram- and saline-treated animals after 21 days. Elucidation of the molecular mechanisms underlying mental disorders is important for future drug development, where transcription factors might be important drug targets.


Subject(s)
Antidepressive Agents/pharmacology , Brain/drug effects , Citalopram/pharmacology , DNA-Binding Proteins/biosynthesis , Gene Expression/drug effects , Transcription Factors/biosynthesis , Animals , Brain/metabolism , DNA-Binding Proteins/analysis , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Electrophoretic Mobility Shift Assay/methods , Enzyme-Linked Immunosorbent Assay/methods , Gene Expression/physiology , Male , Nuclear Proteins/drug effects , Nuclear Proteins/metabolism , Rats , Rats, Sprague-Dawley , Time Factors , Transcription Factor AP-2 , Transcription Factors/analysis , Transcription Factors/genetics
16.
J Neural Transm (Vienna) ; 109(5-6): 963-75, 2002 May.
Article in English | MEDLINE | ID: mdl-12111482

ABSTRACT

Platelet monoamine oxidase (MAO) activity has been shown to be inversely associated with personality traits such as sensation seeking, impulsiveness and extraversion. Those personality traits have also been linked to vulnerability for substance abuse, e.g. tobacco smoking and early onset or "type 2" alcoholism. Compounds in cigarette smoke have been shown to be inhibitors of MAO, which has led several authors to claim that there is no association between alcoholism, which is the most studied psychiatric condition, and platelet MAO if the effect of smoking is removed. With regard to the association between personality and platelet MAO, authors have in general been cautious. In the present paper we describe a number of results which show that there is such an association, both in clinical series if the effect of smoking is removed and in series where smoking have never taken place. A cornerstone in this regard is the significant association between platelet MAO activity and both behaviour/personality, voluntary alcohol intake and biochemical measures of CNS serotonergic activity in non-human primates. Strong evidence that the regulation of platelet MAO activity takes place on a transcriptional level with an involvement of transcription factors, likely to also regulate central monoaminergic activity, are presented.


Subject(s)
Blood Platelets/enzymology , Monoamine Oxidase/blood , Personality , Smoking , DNA-Binding Proteins/physiology , Humans , Mental Disorders/blood , Transcription Factor AP-2 , Transcription Factors/physiology , Transcription, Genetic/physiology
17.
Hum Genet ; 110(1): 1-7, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11810289

ABSTRACT

Monoamine oxidase A and monoamine oxidase B ( MAOA and MAOB) have been suggested to play a role in psychiatric disorders and/or behavioral traits. We have investigated whether different polymorphisms can account for variations in enzyme activity and/or mRNA levels in human brain. Whereas several association studies have been reported previously, this is the first study of the functional effect of MAO DNA variants in human brain. Four polymorphic changes were analyzed: a VNTR located in the MAOA promoter, a VNTR located in the first intron of the MAOA gene, and two single nucleotide polymorphisms located in exon 8 of MAOA and in intron 13 of MAOB. We studied the association of the variants and the resulting haplotypes, with expression levels and enzyme activities of both monoamine oxidases in human cortical brain autopsies. We did not find a significant association of any single MAOA polymorphism with expression levels or enzyme activity in human brain. We did, however, find an association of a particular haplotype with MAOA enzyme levels ( P=0.03). Our results suggest that a novel functional polymorphism that affects enzyme activity in human brain may exist in MAOA. For MAOB, we found a significant association ( P=0.02) between the MAOB intron 13 alleles and different levels of MAOB enzyme activity in human brain. We postulate that there may be a cis-regulatory element in linkage disequilibrium with the B-SNP13 polymorphisms that alters MAOB enzyme activity in human brain.


Subject(s)
Brain/enzymology , Minisatellite Repeats , Monoamine Oxidase/genetics , Polymorphism, Single Nucleotide , Autopsy , Brain/metabolism , Cerebral Cortex/enzymology , Exons , Gene Expression Regulation, Enzymologic , Genetic Variation , Humans , Introns , Isoenzymes/genetics , Isoenzymes/metabolism , Promoter Regions, Genetic , RNA, Messenger/genetics
18.
Brain Res Brain Res Rev ; 38(1-2): 79-128, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11750928

ABSTRACT

A model for the pathophysiology of depression is discussed in the context of other existing theories. The classic monoamine theory of depression suggests that a deficit in monoamine neurotransmitters in the synaptic cleft is the primary cause of depression. More recent elaborations of the classic theory also implicitly include this postulate, other theories of depression frequently prefer to depart from the monoamine-based model altogether. We suggest that the primary defect emerges in the regulation of firing rates in brainstem monoaminergic neurons, which brings about a decrease in the tonic release of neurotransmitters in their projection areas, an increase in postsynaptic sensitivity, and concomitantly, exaggerated responses to acute increases in the presynaptic firing rate and transmitter release. It is proposed that the initial defect involves, in particular, the noradrenergic innervation from the locus coeruleus (LC). Dysregulation of the LC projection activities may lead in turn to dysregulation of serotonergic and dopaminergic neurotransmission. Failure of the LC function could explain the basic impairments in the processing of novel information, intensive processing of irrational beliefs, and anxiety. Concomitant impairments in the serotonergic neurotransmission may contribute to the mood changes and reduction in the mesotelencephalic dopaminergic activity to loss of motivation, and anhedonia. Dysregulation of CRF and other neuropeptides such as neuropeptide Y, galanin and substance P may reinforce the LC dysfunction and thus further weaken the adaptivity to stressful stimuli.


Subject(s)
Biogenic Monoamines/metabolism , Depression/etiology , Depression/physiopathology , Locus Coeruleus/physiopathology , Neurons/metabolism , Animals , Humans , Neurotransmitter Agents/metabolism , Synaptic Transmission
19.
Prog Neuropsychopharmacol Biol Psychiatry ; 25(8): 1497-511, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11642650

ABSTRACT

1. The effect of gender, smoking and pubertal development on platelet monoamine oxidase (MAO) activity was described in a randomly selected, large sample of 9- and 15-years old healthy children. 2. Platelet MAO activity was measured in 1129 children by a radioenzymatic method with beta-phenylethylamine as the substrate. Smoking habits were reported in an anonymous questionnaire. Pubertal status was assessed visually using Tanner's stages. 3. Boys, younger children and smokers had significantly lower platelet MAO activity than girls, older children and non-smokers, respectively. Girls in Tanner's stage V for breast and pubic hair development had significantly lower MAO than girls in stage IV. 4. Differences in gender, age, pubertal status and smoking habits must be taken into account if the relationship between platelet MAO activity, personality and psychiatric disorders is studied in children.


Subject(s)
Monoamine Oxidase/metabolism , Puberty , Smoking/adverse effects , Adolescent , Age Factors , Blood Platelets/enzymology , Child , Child Behavior Disorders/physiopathology , Female , Humans , Male , Mental Disorders/physiopathology , Monoamine Oxidase/analysis , Personality Disorders/physiopathology , Sex Factors
20.
Neurosci Lett ; 313(1-2): 102-4, 2001 Nov 02.
Article in English | MEDLINE | ID: mdl-11684350

ABSTRACT

The transcription factors AP-2alpha and AP-2beta are implicated to play an important role during embryonic development of different parts of the brain, and in targeted regulation of gene expression in the adult brain. Several monoaminergic genes have binding sites for AP-2 in regulatory regions. We have in the present study, analysed the association between AP-2 levels in the brainstem of rats (n=9) and monoamine levels in the frontal cortex, septum and hippocampus. Several regionally specific correlations were found between AP-2alpha and AP-2beta and specific monoamines in the rat forebrain. The data support our notion that the transcription factor AP-2 family is involved in the regulation of the monoaminergic systems and, therefore, might be involved in the pathophysiology of neuropsychiatric disorders.


Subject(s)
Biogenic Monoamines/metabolism , Brain Stem/metabolism , DNA-Binding Proteins/metabolism , Prosencephalon/metabolism , Transcription Factors/metabolism , Animals , Brain Stem/chemistry , DNA-Binding Proteins/analysis , Dopamine/metabolism , Frontal Lobe/metabolism , Hippocampus/metabolism , Norepinephrine/metabolism , Rats , Septum of Brain/metabolism , Serotonin/metabolism , Transcription Factor AP-2 , Transcription Factors/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...